Esoteric Testing Global Market Analysis 2024


The Global Esoteric Testing Market is projected to reach $44.30 billion by 2028, from a value of $23.43 billion in 2022, by registering a CAGR of 11.2% during the forecast period 2022-2028

SKU: ER1061 Category:
© Epson Research 2021
Share this infographic on
Published Year:
Forecast period:
Report Coverage:

Market Trends and analysis of the crucial market segments across North America, Europe, Asia Pacific and Rest of the World.

Report Format:

5 User License

$ 5,500

  • Access to Five users
  • Print upto 5 copies
  • PDF & Excel Formats

Corporate User License

$ 7,000

  • Unlimited users within company
  • Free Yearly update
  • PDF & Excel Formats

The Global Esoteric Testing Market is projected to reach $44.30 billion by 2028, from a value of $23.43 billion in 2022, by registering a CAGR of 11.2% during the forecast period. The increasing number of medical laboratories, the growing geriatric population, and the increasing prevalence of chronic and infectious diseases are the major factors propelling the growth of the market. However, high costs and a lack of skilled professionals are hampering the market growth. Moreover, emerging technologies and advancements in esoteric tests for personalized medicine are creating ample opportunities across the globe.

Recent Developments

In Nov 2021, ARUP Laboratories collaborated with PacBio on a study intended to evaluate whether the solve rate for rare disease cases can be increased. ARUP Laboratories has purchased a PacBio Sequel IIe system for use in the Utah NeoSeq Project. The project, launched in early 2020, leverages an accelerated sequencing and analysis pipeline intended to provide a genetic diagnosis for patients in the neonatal intensive care unit (NICU) in less than a week.

In May 2021, Labcorp acquired select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra® rheumatoid arthritis (RA) assay. The acquisition of the Vectra test and related IP and other assets complements Labcorp’s prior business activity aimed at bolstering its scientific leadership in RA testing and treatment.

In Feb 2021, Quest Diagnostics collaborated with GRAIL, Inc., to provide phlebotomy services to support Galleri™, GRAIL’s multi-cancer early detection blood test. Quest Diagnostics is committed to providing the broadest access to diagnostic innovation. That includes multi-cancer early detection, an important area of oncology diagnostics with potential to radically improve cancer screening, monitoring, and treatment.

In Jan 2021, OPKO Health, Inc launched Scarlet Health™, an in-home, fully integrated digital platform providing access to on-demand diagnostic services. Scarlet has been designed similarly to tools consumers use daily, to provide ease of use and ubiquitous conveniences.

Competitive Landscape

ZeptoMetrix Corporation, Quest Diagnostics, ARUP Laboratories, Nordic Laboratories, Leo Labs, Inc, BP Healthcare Group, Grifols, S.A, Fulgent Genetics Inc, Labcorp, Miraca Holdings Inc, Genomic Health, Inc, bioMontr Labs, American Esoteric Laboratories,
OPKO Health, Inc, and Gold Standard Diagnostics Corp are some of the major players in the global Esoteric Testing market.


1 Summary
2 Market Overview
2.1 Abstract
2.2 Research Sources
2.3 Research Findings
2.4 Assumptions
3 Market Dynamics
3.1 Drivers & Opportunities
3.2 Restraints & Threats
3.3 Regulatory Affairs
3.4 Supplychain Analysis
3.5 PORTERS Analysis
4 Competitive Landscape
5 Esoteric Testing Market by Technology
5.1 Real-Time Polymerase Chain Reaction (RT-PCR)
5.2 Enzyme-Linked Immunosorbent Assay (ELISA)
5.3 Mass Spectrometry (MS)
5.4 Flow Cytometry
5.5 DNA Sequencing
5.6 Chemiluminescence Immunoassay (CLIA)
5.7 Radio Immunoassay
6 Esoteric Testing Market by Type
6.1 Toxicology
6.2 Serology
6.3 Oncology
6.4 Neurology Testing
6.5 Molecular Diagnostics
6.6 Infectious Disease
6.7 Genetic Testing
6.8 Endocrinology Testing
6.9 Microbiology
6.10 Genomics
6.11 Immunology
7 Esoteric Testing Market by Application
7.1 Medical
7.2 Chemical Industry
7.3 Bioengineering
8 Esoteric Testing Market by End User
8.1 Clinical Research Laboratories and Medical Institutes
8.2 Hospital-Based Laboratories
8.3 Independent & Reference Laboratories
9 Esoteric Testing Market by Regions
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Rest of the World
10 Company Profiles
10.1 ZeptoMetrix Corporation
10.2 Quest Diagnostics
10.3 ARUP Laboratories
10.4 Nordic Laboratories
10.5 Leo Labs, Inc
10.6 BP Healthcare Group
10.7 Grifols, S.A
10.8 Fulgent Genetics Inc
10.9 Labcorp
10.10 Miraca Holdings Inc
10.11 Genomic Health, Inc
10.12 bioMontr Labs
10.13 American Esoteric Laboratories
10.14 OPKO Health, Inc
10.15 Gold Standard Diagnostics Corp